vs
ADAMAS TRUST, INC.（ADAM）与Ginkgo Bioworks Holdings, Inc.（DNA）财务数据对比。点击上方公司名可切换其他公司
ADAMAS TRUST, INC.的季度营收约是Ginkgo Bioworks Holdings, Inc.的1.3倍（$43.2M vs $33.4M），ADAMAS TRUST, INC.同比增速更快（61.6% vs -23.8%），ADAMAS TRUST, INC.自由现金流更多（$125.9M vs $-47.7M），过去两年ADAMAS TRUST, INC.的营收复合增速更高（55.5% vs -6.2%）
Ginkgo Bioworks Holdings, Inc.是一家2008年由五名麻省理工学院科学家创立的美国生物技术企业，由杰森·凯利掌舵。公司专注于基因工程改造，为其他生物科技企业开发具备工业应用价值的菌株，帮助合作方省去合成生物学设计初期的重复研发成本，号称「生物制造平台企业」，2019年估值就已达42亿美元。
ADAM vs DNA — 直观对比
营收规模更大
ADAM
是对方的1.3倍
$33.4M
营收增速更快
ADAM
高出85.5%
-23.8%
自由现金流更多
ADAM
多$173.6M
$-47.7M
两年增速更快
ADAM
近两年复合增速
-6.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $43.2M | $33.4M |
| 净利润 | $53.5M | — |
| 毛利率 | — | — |
| 营业利润率 | — | -211.9% |
| 净利率 | 124.0% | — |
| 营收同比 | 61.6% | -23.8% |
| 净利润同比 | 270.5% | — |
| 每股收益（稀释后） | $0.45 | $-1.41 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ADAMDNA
| Q4 25 | $43.2M | $33.4M | ||
| Q3 25 | $36.6M | $38.8M | ||
| Q2 25 | $36.4M | $49.6M | ||
| Q1 25 | $33.1M | $48.3M | ||
| Q4 24 | $26.7M | $43.8M | ||
| Q3 24 | $20.2M | $89.0M | ||
| Q2 24 | $19.0M | $56.2M | ||
| Q1 24 | $17.9M | $37.9M |
净利润ADAMDNA
| Q4 25 | $53.5M | — | ||
| Q3 25 | $44.8M | $-80.8M | ||
| Q2 25 | $8.5M | $-60.3M | ||
| Q1 25 | $42.2M | $-91.0M | ||
| Q4 24 | $-31.4M | — | ||
| Q3 24 | $42.8M | $-56.4M | ||
| Q2 24 | $-15.6M | $-217.2M | ||
| Q1 24 | $-57.9M | $-165.9M |
营业利润率ADAMDNA
| Q4 25 | — | -211.9% | ||
| Q3 25 | — | -231.8% | ||
| Q2 25 | 11.7% | -132.1% | ||
| Q1 25 | — | -184.1% | ||
| Q4 24 | -119.0% | -236.3% | ||
| Q3 24 | — | -62.0% | ||
| Q2 24 | -124.7% | -396.7% | ||
| Q1 24 | -448.8% | -469.1% |
净利率ADAMDNA
| Q4 25 | 124.0% | — | ||
| Q3 25 | 122.5% | -207.9% | ||
| Q2 25 | 23.4% | -121.6% | ||
| Q1 25 | 127.4% | -188.2% | ||
| Q4 24 | -117.5% | — | ||
| Q3 24 | 211.7% | -63.3% | ||
| Q2 24 | -81.9% | -386.4% | ||
| Q1 24 | -324.1% | -437.3% |
每股收益（稀释后）ADAMDNA
| Q4 25 | $0.45 | $-1.41 | ||
| Q3 25 | $0.36 | $-1.45 | ||
| Q2 25 | $-0.04 | $-1.10 | ||
| Q1 25 | $0.33 | $-1.68 | ||
| Q4 24 | $-0.46 | $-1.91 | ||
| Q3 24 | $0.36 | $-1.08 | ||
| Q2 24 | $-0.29 | $-4.23 | ||
| Q1 24 | $-0.75 | $-3.32 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $210.3M | $422.6M |
| 总债务越低越好 | $735.8M | — |
| 股东权益账面价值 | $1.4B | $508.6M |
| 总资产 | $12.6B | $1.1B |
| 负债/权益比越低杠杆越低 | 0.52× | — |
8季度趋势，按日历期对齐
现金及短期投资ADAMDNA
| Q4 25 | $210.3M | $422.6M | ||
| Q3 25 | $185.3M | $495.5M | ||
| Q2 25 | $160.4M | $559.4M | ||
| Q1 25 | $177.1M | $325.3M | ||
| Q4 24 | $167.4M | $561.6M | ||
| Q3 24 | $195.1M | $616.2M | ||
| Q2 24 | $235.5M | $730.4M | ||
| Q1 24 | $226.9M | $840.4M |
总债务ADAMDNA
| Q4 25 | $735.8M | — | ||
| Q3 25 | $766.6M | — | ||
| Q2 25 | $653.0M | — | ||
| Q1 25 | $654.4M | — | ||
| Q4 24 | $573.2M | — | ||
| Q3 24 | $699.4M | — | ||
| Q2 24 | $800.7M | — | ||
| Q1 24 | $1.0B | — |
股东权益ADAMDNA
| Q4 25 | $1.4B | $508.6M | ||
| Q3 25 | $1.4B | $559.8M | ||
| Q2 25 | $1.4B | $613.0M | ||
| Q1 25 | $1.4B | $647.4M | ||
| Q4 24 | $1.4B | $716.1M | ||
| Q3 24 | $1.4B | $797.9M | ||
| Q2 24 | $1.4B | $833.1M | ||
| Q1 24 | $1.5B | $987.3M |
总资产ADAMDNA
| Q4 25 | $12.6B | $1.1B | ||
| Q3 25 | $12.4B | $1.2B | ||
| Q2 25 | $10.6B | $1.2B | ||
| Q1 25 | $10.0B | $1.3B | ||
| Q4 24 | $9.2B | $1.4B | ||
| Q3 24 | $8.9B | $1.5B | ||
| Q2 24 | $8.2B | $1.6B | ||
| Q1 24 | $7.4B | $1.6B |
负债/权益比ADAMDNA
| Q4 25 | 0.52× | — | ||
| Q3 25 | 0.55× | — | ||
| Q2 25 | 0.47× | — | ||
| Q1 25 | 0.47× | — | ||
| Q4 24 | 0.41× | — | ||
| Q3 24 | 0.48× | — | ||
| Q2 24 | 0.56× | — | ||
| Q1 24 | 0.67× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $134.0M | $-47.7M |
| 自由现金流经营现金流 - 资本支出 | $125.9M | $-47.7M |
| 自由现金流率自由现金流/营收 | 291.6% | -142.8% |
| 资本支出强度资本支出/营收 | 18.9% | 0.0% |
| 现金转化率经营现金流/净利润 | 2.50× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ADAMDNA
| Q4 25 | $134.0M | $-47.7M | ||
| Q3 25 | $6.9M | $-31.6M | ||
| Q2 25 | $39.2M | $-40.3M | ||
| Q1 25 | $25.8M | $-51.5M | ||
| Q4 24 | $14.1M | $-42.4M | ||
| Q3 24 | $-922.0K | $-103.5M | ||
| Q2 24 | $-993.0K | $-84.4M | ||
| Q1 24 | $-13.1M | $-89.3M |
自由现金流ADAMDNA
| Q4 25 | $125.9M | $-47.7M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-40.3M | ||
| Q1 25 | — | $-59.1M | ||
| Q4 24 | $-10.6M | $-56.1M | ||
| Q3 24 | $-8.6M | $-118.6M | ||
| Q2 24 | $-8.6M | $-111.4M | ||
| Q1 24 | $-19.1M | $-96.0M |
自由现金流率ADAMDNA
| Q4 25 | 291.6% | -142.8% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -81.2% | ||
| Q1 25 | — | -122.4% | ||
| Q4 24 | -39.6% | -128.0% | ||
| Q3 24 | -42.3% | -133.2% | ||
| Q2 24 | -44.9% | -198.2% | ||
| Q1 24 | -107.0% | -252.9% |
资本支出强度ADAMDNA
| Q4 25 | 18.9% | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 15.8% | ||
| Q4 24 | 92.3% | 31.3% | ||
| Q3 24 | 37.7% | 16.9% | ||
| Q2 24 | 39.7% | 48.1% | ||
| Q1 24 | 33.5% | 17.7% |
现金转化率ADAMDNA
| Q4 25 | 2.50× | — | ||
| Q3 25 | 0.15× | — | ||
| Q2 25 | 4.59× | — | ||
| Q1 25 | 0.61× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.02× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ADAM
| Other | $19.6M | 45% |
| Constructive Loans LLC | $14.4M | 33% |
| Multifamily | $9.1M | 21% |
DNA
| Cell Engineering Segment | $26.0M | 78% |
| Other | $7.4M | 22% |
